当代医学
噹代醫學
당대의학
CHINA CONTEMPORARY MEDICINE
2015年
3期
3-5
,共3页
郭清%蒋美媛%饶华清%蒙英英
郭清%蔣美媛%饒華清%矇英英
곽청%장미원%요화청%몽영영
超声%药物干预%高血压%颈动脉弹性功能
超聲%藥物榦預%高血壓%頸動脈彈性功能
초성%약물간예%고혈압%경동맥탄성공능
Ultrasonic%Drug intervention%High blood pressure%Carotid artery elastic function
目的研究分析超声评价药物干预治疗高血压病患者颈动脉弹性功能变化情况。方法将126例高血压组患者分为2组:药物干预组62例(A组)和非干预组64例(B组),50位健康人为对照组(C组)。药物干预组采用普罗布考联合阿司匹林、阿托伐他汀治疗,口服普罗布考0.5g,2次/d,阿司匹林100 mg,1次/d,阿托伐他汀10 mg,1次/d,服用12周;非干预组不服用上述药物,其他降压等治疗措施均与干预组一致;然后用超声技术检测IMT、收缩末内径和舒张末内径,观察IMT、IMT/Ds、PP、DS、Dd以及DS-Dd的变化。结果药物干预前高血压A组、B组的mIMT[(1.2±0.2)mm、(1.2±0.3)mm]、IMT/Ds [(13.7±2.0)%、(13.6±1.9)%]均较健康对照组[(0.8±0.1)mm、(11.5±1.6)%]显著升高(P<0.01)。药物干预后A组的PP、DS、Dd[(46.3±6.6)、(7.1±0.9)、6.9±0.8)]降低,DS-Dd(0.6±0.2)增加(P<0.05)。而B组未实施药物干预上述指标无明显变化;A组的TC、TG、LDL-C、hs-CRP、ox-LDL[(4.3±0.3)、(1.3±0.2)、(1.6±0.6)、(2.6±0.6)、(3.4±1.2)、(4.4±1.1)]等各项指标均显著降低(P<0.05),而B组未实施药物干预上述指标无明显变化。结论血管超声可以定量反映高血压病患者药物干预治疗前后血管弹性功能的变化,颈动脉弹性功能对心血管疾病具有独立的预测价值。
目的研究分析超聲評價藥物榦預治療高血壓病患者頸動脈彈性功能變化情況。方法將126例高血壓組患者分為2組:藥物榦預組62例(A組)和非榦預組64例(B組),50位健康人為對照組(C組)。藥物榦預組採用普囉佈攷聯閤阿司匹林、阿託伐他汀治療,口服普囉佈攷0.5g,2次/d,阿司匹林100 mg,1次/d,阿託伐他汀10 mg,1次/d,服用12週;非榦預組不服用上述藥物,其他降壓等治療措施均與榦預組一緻;然後用超聲技術檢測IMT、收縮末內徑和舒張末內徑,觀察IMT、IMT/Ds、PP、DS、Dd以及DS-Dd的變化。結果藥物榦預前高血壓A組、B組的mIMT[(1.2±0.2)mm、(1.2±0.3)mm]、IMT/Ds [(13.7±2.0)%、(13.6±1.9)%]均較健康對照組[(0.8±0.1)mm、(11.5±1.6)%]顯著升高(P<0.01)。藥物榦預後A組的PP、DS、Dd[(46.3±6.6)、(7.1±0.9)、6.9±0.8)]降低,DS-Dd(0.6±0.2)增加(P<0.05)。而B組未實施藥物榦預上述指標無明顯變化;A組的TC、TG、LDL-C、hs-CRP、ox-LDL[(4.3±0.3)、(1.3±0.2)、(1.6±0.6)、(2.6±0.6)、(3.4±1.2)、(4.4±1.1)]等各項指標均顯著降低(P<0.05),而B組未實施藥物榦預上述指標無明顯變化。結論血管超聲可以定量反映高血壓病患者藥物榦預治療前後血管彈性功能的變化,頸動脈彈性功能對心血管疾病具有獨立的預測價值。
목적연구분석초성평개약물간예치료고혈압병환자경동맥탄성공능변화정황。방법장126례고혈압조환자분위2조:약물간예조62례(A조)화비간예조64례(B조),50위건강인위대조조(C조)。약물간예조채용보라포고연합아사필림、아탁벌타정치료,구복보라포고0.5g,2차/d,아사필림100 mg,1차/d,아탁벌타정10 mg,1차/d,복용12주;비간예조불복용상술약물,기타강압등치료조시균여간예조일치;연후용초성기술검측IMT、수축말내경화서장말내경,관찰IMT、IMT/Ds、PP、DS、Dd이급DS-Dd적변화。결과약물간예전고혈압A조、B조적mIMT[(1.2±0.2)mm、(1.2±0.3)mm]、IMT/Ds [(13.7±2.0)%、(13.6±1.9)%]균교건강대조조[(0.8±0.1)mm、(11.5±1.6)%]현저승고(P<0.01)。약물간예후A조적PP、DS、Dd[(46.3±6.6)、(7.1±0.9)、6.9±0.8)]강저,DS-Dd(0.6±0.2)증가(P<0.05)。이B조미실시약물간예상술지표무명현변화;A조적TC、TG、LDL-C、hs-CRP、ox-LDL[(4.3±0.3)、(1.3±0.2)、(1.6±0.6)、(2.6±0.6)、(3.4±1.2)、(4.4±1.1)]등각항지표균현저강저(P<0.05),이B조미실시약물간예상술지표무명현변화。결론혈관초성가이정량반영고혈압병환자약물간예치료전후혈관탄성공능적변화,경동맥탄성공능대심혈관질병구유독립적예측개치。
Objective To study the analysis of ultrasonic evaluation of drug intervention treatment of high blood pressure patients carotid artery elastic function changes.Methods Hypertension patients divided into two groups: drug intervention group (group A) and the intervention group (group B), healthy control group (group C).Drug intervention group (ordinary cloth combined aspirin and atorvastatin) oral profumo burqa 0.5 g, 2 times a day, 100 mg of aspirin, 1 x per day, atorvastatin 10 mg, 1 times a day, 12 weeks, and then use ultrasound detecting IMT , shrinkage end inner diameter and end-diastolic diameter , observe the IMT, IMT/Ds, PP , Ds and Dd and Ds-Dd.Results Hypertension before drug intervention group A and group B mIMT[ (1.2±0.2)mm,(1.2±0.3)mm], IMT/Ds [(13.7±2.0)%,(13.6±1.9)%]were significantly increased compared with healthy controls[(0.8±0.1) mm,(11.5±1.6)%] (P<0.01).After the drug intervention group APP, DS, Dd [(46.3±6.6),(7.1±0.9), (6.9±0.8)]is reduced, the DS - Dd(0.6±0.2)increased (P< 0.05).And not the drug intervention group B has no obvious change;Group A TC TG,LDL-C, hs - CRP, ox - LDL[(4.3±0.3),(1.3±0.2),(1.6±0.6) ,(2.6±0.6),(3.4±1.2),(4.4±1.1l)], and other indicators were significantly lower (P<0.05),and not the drug intervention group B has no obvious change. Conclusion Vascular ultrasound can quantitatively reflect the high blood pressure patients drug intervention treatment before and after the change of the function of blood vessel elasticity, carotid artery elastic function have independent predictive value for cardiovascular disease.